Why the study?
The impact of D-dimer on long-term mortality in patients with coronary artery disease remained unclear.
Do high D-dimer levels predict long-term mortality in patients with CAD after PCI?
Do high D-dimer levels predict long-term mortality in patients with CAD after PCI?
High D-dimer levels at admission independently predict long-term all-cause, cardiac, and cancer mortality in patients with CAD surviving to discharge after PCI.
Answers are grounded in this paper and cite their sources.
High D-dimer may aid post-PCI risk stratification in CAD; extends observational data but leaves open prospective validation.
D-dimer is a common measurable coagulation marker that is associated with the risk of thrombotic events in vascular diseases. However, the impact of D-dimer on long-term mortality in coronary artery disease (CAD) patients remains unclear. This study investigated the association between D-dimer and long-term all-cause, cardiac and cancer mortality in CAD patients. Continuous 1,440 patients with CAD who underwent percutaneous coronary intervention (PCI) and survived to discharge were enrolled. These patients were divided into 3 groups based on plasma D-dimer levels at admission. Baseline D-dimer levels were grouped by tertiles: first (D-dimer < 0.7 μg/mL, n = 455), second (0.7 ≤ D-dimer < 1.2, n = 453), and third (1.2 ≤ D-dimer, n = 532). In a Kaplan-Meier analysis (mean follow-up periods 1,572 days), all-cause, cardiac and cancer mortalities were significantly higher in the third tertile than others (P < 0.001, P < 0.001 and P < 0.001, respectively). In multivariable Cox proportional hazard analyses after adjusting for confounding factors, a high D-dimer level was an independent predictor of all-cause, cardiac, non-cardiac and cancer mortalities (HR 3.23, P < 0.001; HR 3.06, P = 0.008; HR 3.11, P = 0.026). In a subgroup analysis, there were no interactions except for the gender subgroup in cancer mortality. In patients with CAD after PCI, high D-dimer levels were associated with long-term all-cause, cardiac and cancer mortality.
No takes yet. Share an insight, caveat, or question.
Kurosawa et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: